J. Fruebis

发表

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.

H. Lodish, T. Tsao, B. Bihain, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Measuring cone density in a Japanese macaque (Macaca fuscata) model of age-related macular degeneration with commercially available adaptive optics.

Anupam K. Garg, Travis B. Smith, Sawan Hurst, 2014, Advances in experimental medicine and biology.

Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis.

W. Palinski, J. Fruebis, M. Silvestre, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis.

P. Reaven, J. Fruebis, M. Silvestre, 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen.

J. Ellsworth, P. Sheppard, José A López, 2006, Blood.

Evidence for a concerted reaction between lipid hydroperoxides and polypeptides.

D. Steinberg, S. Parthasarathy, J. Fruebis, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

J. Witztum, S. Parthasarathy, J. Fruebis, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice.

D. Steinberg, R. Tangirala, W. Palinski, 1998, Journal of lipid research.

Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants.

W. Palinski, J. Fruebis, D. A. Bird, 1997, Journal of lipid research.

Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits.

T. Carew, W. Palinski, J. Fruebis, 1995, Atherosclerosis.

Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits.

C. Napoli, W. Palinski, J. Fruebis, 1999, Journal of lipid research.

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

J. Oldenburg, E. Santagostino, B. Konkle, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.

D. Quon, J. Staber, B. Konkle, 2020, The New England journal of medicine.

Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

J. Oldenburg, M. Ozelo, H. Chambost, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

A Zymogen-like Factor Xa Improves Hemostasis in a Murine Bleeding Model

R. Camire, S. Patel-Hett, J. Fruebis, 2014 .

BIVV001: The First Investigational Factor VIII Therapy to Break Through the VWF Ceiling in Hemophilia A, with Potential for Extended Protection for One Week or Longer

D. Quon, J. Staber, B. Konkle, 2018, Blood.

A Novel FVIIa Variant with Increased Potency and Duration of Effect Compared to Wildtype FVIIa. A Study in a Dog Model of Hemophilia A

T. Nichols, S. Arkin, C. Parng, 2011 .

ACRP30, a new hormone controlling fat and glucose metabolism.

H. Lodish, T. Tsao, J. Fruebis, 2002, European journal of pharmacology.

Sutimlimab in Cold Agglutinin Disease.

T. Tvedt, Y. Miyakawa, B. Jilma, 2021, The New England journal of medicine.

Measurement of gene expression in the vascular wall by reverse transcription-polymerase chain reaction (rt-PCR) analysis.

J. Fruebis, 1999, Methods in molecular medicine.

A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.

T. Carew, D. Steinberg, J. Fruebis, 1994, The Journal of clinical investigation.